The European Patent Office (EPO) and the China National Intellectual Property Administration (CNIPA) are both seeing a rise in the number of patents filed in the pharmaceutical and biotechnology sectors. What can be patented in each of these jurisdictions?
Join Gene Quinn, patent attorney and the founder of IPWatchdog.com, for a webinar discussion on Thursday, January 28th at 12 pm EST relating to what types of life sciences innovations can be patented at the EPO and CNIPA. Gene will be joined by Niklas Mattsson, a European Patent Attorney and Partner at AWA, and Hai Liu, Senior Patent Attorney with AWA Asia.
This webinar will consider the patenting of life sciences inventions before the EPO and the CNIPA, specifically addressing patentable subject matter as it applies to genes, proteins, stem cells, methods of treatment and methods of diagnosis in both jurisdictions. Niklas and Hai will also discuss supporting requirements and the availability of post-filing data.